Individuals Coming Off Slimming Medications Gain Back Pounds Four Times Faster Than Dieters

New research reveals that people who stop using blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover lost weight far faster than those who stop traditional lifestyle programs.

Research printed in a major health publication points out that while obese people can lose substantial amounts of their total mass while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"Individuals purchasing these treatments need to be cognizant of the risk of rapid rebound weight gain when the therapy is stopped," warns researcher Dr. Susan Jebb.

Such speed of recovery means a reversion to original weight in about 18 months.

Comparing Therapies

The research, which looked at dozens of trials involving thousands of participants, contrasted the results of these new drugs with older methods.

Scientists point out that individuals who lose weight through lifestyle changes alone usually see a slower weight regain—perhaps 100 grams monthly—once they finish.

Understanding the Fast Rebound

Nutrition scientists believe the way of the injections explains the accelerated weight return.

GLP-1 drugs mimic a natural hormone called GLP-1, which moderates feelings of fullness.

"Artificially providing GLP-1 levels far above than normal could lead to the system to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this medication means hunger is uncontrolled, making excessive eating far more likely."

An Ongoing Condition?

Health authorities suggest the injections for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.

A number of clinicians contend that, considering the high risk of relapse, the treatment is often long-term.

This opinion is reinforced by drug manufacturers, who state that the findings "highlight the long-term character of obesity," similar to managing conditions like high blood pressure.

User Experiences

Users who have come off the medication explain a sudden resurgence of cravings.

"I experienced a trigger that goes on and I was suddenly extremely hungry," recalled an individual.

The struggle is worsened if individuals have not developed sustainable dietary or behavioural modifications during treatment.

Widespread Interest

Survey data show that a significant number of people in the UK have tried these injections in the last 12 months, with desire being substantial.

• Use is more common among women than men.
• The middle-aged demographic shows the highest usage rates.
• Many obtain the drugs through private healthcare rather than the NHS.

In conclusion, researchers stress that while the jabs are effective agents for shedding pounds, they are not a magic solution and maintained weight loss likely depends on ongoing lifestyle support.